Key result
Baseline non-sustained VT linked to ~9.7-fold higher risk of sustained VT in Chagas cardiomyopathy.
Why the study?
Ventricular tachycardia is a major cause of sudden death in Chagas cardiomyopathy, and identifying patients at risk requires understanding the structural substrate and its echocardiographic and electrocardiographic predictors.
Does combined echocardiographic and electrocardiographic assessment predict sustained ventricular tachycardia in patients with chronic Chagas cardiomyopathy?
Cohort (n=50)
No
Does combined echocardiographic and electrocardiographic assessment predict sustained ventricular tachycardia in patients with chronic Chagas cardiomyopathy?
In chronic Chagas cardiomyopathy, the combined presence of non-sustained VT on Holter, anteroseptal inactive area on ECG, and LV apical aneurysm on echocardiography strongly identifies patients at high risk for sustained ventricular tachycardia.
May aid VT risk stratification in Chagas cardiomyopathy; leaves open whether markers guide interventions in prospective studies.
Introduction Ventricular tachycardia (VT) is a major cause of sudden death in Chagas cardiomyopathy. Identifying patients at risk requires understanding the structural substrate. We sought to investigate the incidence of VT and its echocardiographic and electrocardiographic predictors. Methods We studied 50 patients with chronic Chagas cardiomyopathy (age 51±9 years, 70% female), all in sinus rhythm at baseline, followed at a tertiary center (mean 83.5±40.7 months). Sustained VT was documented by serial Holter and ECG monitoring. LA volume (from anteroposterior diameter using spherical model), LV mass (Devereux), and LVEF (Teichholz) were derived by echocardiography from the parasternal long-axis view at admission. LV apical aneurysm, inactive area on ECG, and non-sustained VT (NSVT) on Holter were recorded at baseline. Given the limited number of events, predictors were assessed by Firth-penalized Cox proportional hazards regression to reduce bias. Hazard ratios (HR) for continuous variables are expressed per unit increase. Results were validated by bootstrap resampling (2,000 iterations). Results VT occurred in 11 patients (22%), with an incidence of 3.16/100 person-years (95%CI 1.58–5.66). The composite of VT or death occurred in 17 patients (34%; 4.89/100 person-years). Among five patients with both VT and atrial fibrillation, VT preceded AF (100%). Patients who developed VT had increased baseline LV mass (199.9±49.3 g vs 156.0±64.6 g; p=0.012) and larger LV end-systolic diameter (4.05±1.18 cm vs 3.14±1.04 cm; p=0.012) (Figures A2 and A3). On Firth-penalized Cox regression (Figure B), VT predictors were baseline NSVT (HR=9.69; 95%CI [2.78–33.7]; p<0.001), LV apical aneurysm (HR=7.48; 95%CI [2.20–25.5]; p=0.001), inactive area on ECG (HR=3.63; 95%CI [1.11–11.9]; p=0.033), driven by anteroseptal location (HR=6.18; 95%CI [1.87–20.4]; p=0.003) rather than inferior (p=0.74), LV end-systolic diameter (HR=1.83/cm; 95%CI [1.22–2.73]; p=0.004), LV end-diastolic diameter (HR=1.89/cm; 95%CI [1.16–3.1]; p=0.011) and LVEF (HR=0.957/%; 95% CI [0.93–1.0]; p=0.008). Anteroseptal inactive area and LV apical aneurysm were strongly associated (OR=11.7; p=0.006), and the presence of both findings was associated with a VT rate of 80% (4/5). In a two-predictor model, both NSVT (HR=7.53; 95%CI [2.03–27.9]; p=0.003) and anteroseptal inactive area (HR=3.83; 95%CI [1.05–13.9]; p=0.042) remained independent predictors of VT. Bootstrap validation confirmed NSVT, LV apical aneurysm, anteroseptal inactive area, LV end-systolic diameter, LV end-diastolic diameter and LVEF as stable predictors (Figure B). Conclusion In Chagas cardiomyopathy, a high-risk arrhythmogenic phenotype is driven by structural remodeling and electrical instability. The combined detection of NSVT, anteroseptal scar, and LV apical aneurysm strongly predicts VT, supporting early risk stratification using combined echocardiographic and electrocardiographic assessment.
No takes yet. Share an insight, caveat, or question.
Barbosa et al. (2026) conducted a cohort in Chronic Chagas cardiomyopathy (n=50). Baseline non-sustained VT, LV apical aneurysm, and anteroseptal inactive area on ECG vs. Absence of structural and electrical remodeling predictors was evaluated on Sustained ventricular tachycardia (VT) (HR 9.69, 95% CI 2.78-33.7, p=<0.001). Baseline non-sustained VT (HR 9.69; 95% CI 2.78-33.7), LV apical aneurysm (HR 7.48), and anteroseptal scar (HR 6.18) strongly predicted sustained VT in Chagas cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: